Asia-Pacific Journal of Clinical Oncology

Papers
(The H4-Index of Asia-Pacific Journal of Clinical Oncology is 12. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
An inverse stage‐shift model to estimate the excess mortality and health economic impact of delayed access to cancer services due to the COVID‐19 pandemic51
COVID‐19 vaccination rates, intent, and hesitancy in patients with solid organ and blood cancers: A multicenter study24
Measuring financial toxicity in Australian cancer patients – Validation of the COmprehensive Score for financial Toxicity (FACT COST) measuring financial toxicity in Australian cancer patients24
Incidence, mortality, survival, and disease burden of breast cancer in China compared to other developed countries21
A systematic review of the barriers to implementing human papillomavirus vaccination programs in low‐ and middle‐income countries in the Asia‐Pacific19
Overview of epidemiological characteristics, clinical features, and risk factors of gastric cancer in Asia‐Pacific region17
Roles of Myc‐associated zinc finger protein in malignant tumors15
Metabolic profiling analysis for clinical urine of colorectal cancer13
Increased TOX expression concurrent with PD‐1, Tim‐3, and CD244 in T cells from patients with non‐Hodgkin lymphoma13
Screening and surveillance for gastric cancer: Does family history play an important role in shaping our strategy?13
Tripartite motif‐containing 54 promotes gastric cancer progression by upregulating K63‐linked ubiquitination of filamin C12
Short‐term multimodal prehabilitation improves functional capacity for colorectal cancer patients prior to surgery12
0.045046091079712